TREY ROWE: Open Payments
NPI 1720735418 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 13 payments from 9 companies in 2025. Trend: 2023 $297 · 2024 $175 · 2025 $806
Food & beverage: $806
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $247 |
| Sumitomo Pharma America, Inc. | 2 | $208 |
| Telix Pharmaceuticals | 1 | $89 |
| Ferring Pharmaceuticals Inc. | 1 | $89 |
| PFIZER INC. | 3 | $70 |
| Procept Biorobotics Corporation | 1 | $35 |
| Dendreon Pharmaceuticals LLC | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: RYBREVANT, ORGOVYX, XTANDI, ILLUCCIX, ADSTILADRIN, GEMTESA, AQUABEAM ROBOTIC SYSTEM, PROVENGE.
Industry payments across FL — which companies pay providers there.
